Boston Trust Walden’s Entegris ENTG Stock Holding History

Boston Trust Walden’s Portfolio ENTG Stock Details ENTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,101	Closed	-$276K	–	376
2022 Q1	$276K	Buy	+2,101	New	+$270K	﹤0.01%	359

Other funds holding ENTG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Trust Walden's ENTG Position: Q2 2022 in Review

Boston Trust Walden sold out of Entegris (ENTG) in Q2 2022, closing a stake of 2,101 shares — an estimated $276K sold.

Boston Trust Walden first reported a position in ENTG in Q1 2022 and held it in 1 quarter. The position peaked at $276K in Q1 2022. 500 funds tracked by Wall St. Rank hold ENTG as of Q2 2022.

Boston Trust Walden reported no remaining Entegris position as of Q2 2022 after selling out during the quarter.
Boston Trust Walden sold 2,101 Entegris shares in Q2 2022, an estimated $276K.
Boston Trust Walden first reported a position in Entegris in Q1 2022 and held it in 1 quarter.
Boston Trust Walden's Entegris position peaked at $276K in Q1 2022.
500 funds tracked by Wall St. Rank held Entegris as of Q2 2022.

Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.